Jefferies Top Stocks to Buy Offer Solid Dividend Yields
These four top stocks to buy have outstanding value characteristics and solid dividend yields. They make sense for balanced portfolios looking for growth and income.
These four top stocks to buy have outstanding value characteristics and solid dividend yields. They make sense for balanced portfolios looking for growth and income.
Jefferies searches for growth with reasonable valuations and upside potential. This week's picks are no exception to that rule.
These top companies are big internet players in their respective fields, and all continue to dominate their opposition in ways that are almost impossible to overcome.
What should investors look for now? A combination of integrated leaders and Permian Basin companies that are nimble and doing an outstanding job in keeping costs low.
While the insider selling was steady, it was nothing that resembled anything other than normal selling. With the markets trading at all-time highs investors can expect more of the same.
It is an incredibly bullish sign for the markets to see insiders adding shares at these levels, especially in the traditionally slow month of August.
Dividend aristocrats are members of the S&P 500 that have increased their dividends for at least 20 consecutive years. These are four that investors can buy now and hold forever.
One sector that continues to grow is health care, and the health care real estate investment trusts that have traded higher still offer outstanding distributions.
All three of these specialty pharmaceutical stocks come with a fair share of risk but provide big upside potential as well.
With the gas prices expected to remain low at least through this year, and probably in to 2017, the consumers now may be looking to buy some of the things they want and need…
These three outstanding companies continue to be favorites across Wall Street. All are participating in the basin many think is the best in the country, and all are extremely well run.
Investors are now focusing on fundamentals and near-term catalysts that could provide a tailwind for some of the biotech leaders.
While there is no guarantee that these stocks all thrive after the November election, they all have very strong and mature franchises that should continue to drive earnings regardless of who sits in the…
A new UBS research report makes the case that oil services earnings are starting to surprise to the upside somewhat.
A new Jefferies research report has four new growth stocks to buy that could have some serious upside potential.
The analysts at Stifel have noted three biotech companies that not only have data that could prove to be huge, but also have stocks that have been absolutely hammered over the past year.
In a new research report from Jefferies, top-notch equity strategist Steven DeSanctis makes the case that now is the time to rotate to growth stocks from value, and he sees relative valuations still very…
RBC makes the case that earnings so far this year are relatively stronger than some anticipated, and it notes that companies that did come in with positive earnings surprises were treated well by investors.
With the dollar's strength abating and the economy growing, albeit slowly, the analysts at RBC are staying positive on the current market.
In a recent research note, the analysts at Jefferies made a big move by adding Ball Corp. to the firm's well-respected Franchise Picks list of stocks to buy.